Structure and functional dynamics of virus-host protein interactions

病毒-宿​​主蛋白相互作用的结构和功能动力学

基本信息

  • 批准号:
    9789044
  • 负责人:
  • 金额:
    $ 31.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-20 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

The 1918 influenza A virus (IAV), also known as the Spanish flu, caused the worst influenza pandemic in human history. Nonstructural protein 1 (NS1) is a multifunctional virulence factor associated with the suppression of anti- viral immune responses and thereby has been identified as one of the molecular determinants of high pathogenicity of the 1918 IAV. NS1 of the 1918 IAV (1918 NS1) contains a proline-rich motif (PRM) that mediates binding with host CrkII with high affinity and selectivity. The 1918 NS1:CrkII interaction plays critical roles in the suppression of host anti-viral immune responses and the enhancement of viral replication. Moreover, NS1s of many avian/swine IAVs contain the CrkII-binding PRM. Given the zoonotic potential of IAVs, there is a critical need to determine the molecular mechanisms by which the interaction of 1918 NS1 and cellular CrkII is regulated. The long-term goal of our research program is to elucidate the molecular mechanisms underlying virus-host protein interactions. Our objectives in this proposal are to determine the structural mechanisms of the 1918 NS1:CrkII interaction, and to determine the molecular and cellular mechanisms whereby the 1918 NS1:CrkII complex induces PI3K activation, resulting in enhanced viral replication. Our central hypothesis is that the 1918 NS1:CrkII complex is structurally dynamic, which is functionally important for the interaction with the p85 regulatory subunit of PI3K. To test this hypothesis, we will determine the structure of the 1918 NS1:CrkII complex and elucidate how the complex interacts with p85 to activate the PI3K signaling pathway. Our rationale for these studies is that the mechanistic understanding of the interactions of 1918 NS1 with CrkII and p85 would help identify previously undiscovered target sites to develop for potential inhibitors against the 1918 NS1. Through a synergistic approach combining small-angle X-ray scattering, NMR spectroscopy, molecular dynamics simulation, and cell-based assays, we will pursue the following specific aims. Aim 1. To determine the structural mechanism of the 1918 NS1:CrkII interaction using a battery of biophysical experiments. Hijacking and relocation of CrkII into the nucleus is a distinctive feature of the 1918 pandemic IAV NS1. To understand this process, we will reveal structural and energetic mechanisms by which the affinity and lifetime (1/koff) of the 1918 NS1:CrkII complex are modulated. Aim 2. To determine the molecular mechanism underlying NS1-induced PI3K activation. The 1918 NS1:CrkII interaction markedly enhances NS1-induced PI3K activation; however, its molecular mechanism is unknown. We will seek to comprehensively determine the molecular mechanisms by which the 1918 NS1:CrkII complex interacts with the p85 subunit of PI3K, reveal its functional role in PI3K activation, and identify hotspot NS1 residues that interact with both CrkII and p85. This study is expected to have a positive impact on the development of anti-viral agents targeting NS1-host protein interactions.
1918年甲型流感病毒(IAV),也被称为西班牙流感,导致了人类最严重的流感大流行 历史。非结构蛋白1(NS1)是一种多功能毒力因子,与抑制抗病毒相关。 病毒免疫反应,因此已被确定为高水平的分子决定因素之一 1918年IAV的致病性。1918年IAV的NS1(1918NS1)包含一个富含脯氨酸的基序(PRM),它介导 与宿主CrkII结合具有高亲和力和选择性。1918年NS1:CrkII的相互作用在 抑制宿主抗病毒免疫反应,增强病毒复制。此外,NS1的 许多禽类/猪IAV都含有与CrkII结合的PRM。鉴于IAV的人畜共患病潜力,有一个关键的 需要确定1918NS1和细胞CrkII相互作用的分子机制。 我们研究计划的长期目标是阐明病毒宿主的分子机制。 蛋白质的相互作用。我们在这项提案中的目标是确定1918年的结构机制 NS1:CrkII相互作用,并确定1918年NS1:CrkII的分子和细胞机制 复合体诱导PI3K激活,导致病毒复制增强。我们的中心假设是1918年 Ns1:CrkII复合体在结构上是动态的,这对于与P85的相互作用具有重要的功能 PI3K调节亚基。为了验证这一假设,我们将确定1918年NS1:CrkII复合体的结构 并阐明该复合体如何与P85相互作用激活PI3K信号通路。我们对此的理由是 研究表明,从机制上理解1918年ns1与CrkII和p85的相互作用将有所帮助。 确定以前未发现的靶点,以开发针对1918年NS1的潜在抑制剂。通过一个 结合小角X射线散射、核磁共振光谱、分子动力学的协同方法 模拟和基于细胞的分析,我们将追求以下具体目标。目标1.确定结构 用生物物理实验电池研究1918年ns1:crkII相互作用的机制。劫持和重新安置 CrkII进入细胞核是1918年IAV NS1大流行的一个显著特征。为了了解这一过程,我们 将揭示1918年NS1:CrkII的亲和力和寿命(1/koff)的结构和能量机制 复数是调制的。目的2.探讨NS1诱导PI3K活化的分子机制。 1918年NS1:CrkII相互作用显著增强NS1诱导的PI3K激活;但其分子 机制尚不清楚。我们将寻求全面确定分子机制,其中 1918NS1:CrkII复合体与PI3K的P85亚基相互作用,揭示了它在PI3K激活中的功能作用,以及 确定与crkII和p85相互作用的热点ns1残基。这项研究预计将有积极的 对针对NS1-宿主蛋白相互作用的抗病毒药物的开发的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jae Hyun Cho其他文献

Jae Hyun Cho的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jae Hyun Cho', 18)}}的其他基金

Structure and functional dynamics of virus-host protein interactions
病毒-宿​​主蛋白相互作用的结构和功能动力学
  • 批准号:
    10473691
  • 财政年份:
    2018
  • 资助金额:
    $ 31.52万
  • 项目类别:
Structure and functional dynamics of virus-host protein interactions
病毒-宿​​主蛋白相互作用的结构和功能动力学
  • 批准号:
    10000945
  • 财政年份:
    2018
  • 资助金额:
    $ 31.52万
  • 项目类别:
Structure and functional dynamics of virus-host protein interactions
病毒-宿​​主蛋白相互作用的结构和功能动力学
  • 批准号:
    10581354
  • 财政年份:
    2018
  • 资助金额:
    $ 31.52万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 31.52万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 31.52万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 31.52万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 31.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了